secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001213900-23-054818
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics upsized IPO priced at $5.00/share; gross proceeds $19.5M
-------------------------------------------------------------------------------

- Sold 3,900,000 shares at $5.00/share for gross proceeds of $19.5M; net proceeds of $16.2M.
- Underwriters have 45-day option to purchase up to 585,000 additional shares at same price.
- Common stock began trading on Nasdaq Capital Market on June 30, 2023 under ticker 'INTS'.
- Net proceeds to fund clinical trials, operations, product development, and working capital.
- Amended and restated charter and bylaws effective upon closing of IPO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000121390023054818/0001213900-23-054818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000121390023054818/ea181296-8k_intensity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-054818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer